Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP in Knee Osteoarthritis
NCT02468492Phase 1Completed
- Sponsor
- Richmond VA Medical Center
- Start
- Sep 2014
- Primary completion
- Nov 2015
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of autologous platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Richmond VA Medical Center. Primary endpoint: Biochemical Molecular Outcomes at 10 days. Started Sep 2014; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02468492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02468492.